D 400

Known as: D-400 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1995-2017
024619952017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2003
2003
Results of a double-blind placebo-controlled trial of Diabecon (D-400) – an Ayurvedic drug in NIDDM patients with secondary… (More)
  • table 1
Is this relevant?
2003
2003
D-400, herbomineral formulation was evaluated for its effect on blood sugar levels in 28 NIDDM patients. The mean initial fasting… (More)
  • figure 1
Is this relevant?
2003
2003
  • 2003
Efficacy and safety of Diabecon (D-400) was assessed in thirty NIDDM patients (15 freshly diagnosed diabetic patients and 15… (More)
  • table 1
  • table 2
  • table 3
  • table 5
Is this relevant?
2003
2003
  • 2003
Interaction of Diabecon with rifampicin The pharmacokinetic interaction of rifampicin and Diabecon (D-400) was studied in animal… (More)
  • table 1
  • table 2
Is this relevant?
1999
1999
In the present study, Diabecon (D-400), a herbomineral anti-diabetic preparation, was studied for its pharmacokinetic interaction… (More)
  • table I
Is this relevant?
1996
1996
This study was undertaken to investigate the effect of D-400, a herbomineral formulation on blood sugar and other biochemical… (More)
Is this relevant?
1996
1996
Streptozotocin induces severe and irreversible hyperglycaemia in experimental animals. The effect of oral administration of D-400… (More)
Is this relevant?
1996
1996
D-400, a herbomineral preparation has proven antidiabetic activity in experimental models as well as in clinical trials. The… (More)
Is this relevant?
1995
1995
This study was undertaken to investigate D-400, a herbomineral formulation in streptozotocin induced diabetes in rats. Glycated… (More)
Is this relevant?
1995
1995
Blood sugar levels of normal rats treated with D-400 showed significant reduction (P < 0.05) as compared to control groups. The… (More)
  • figure 1
  • figure 2
  • figure 5
  • figure 6
  • figure 7
Is this relevant?